Clearside Biomedical (CLSD) Competitors $0.87 -0.06 (-6.20%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLSD vs. SAGE, JSPR, VALN, CCCC, FDMT, IMMP, CMPS, ACIU, AMLX, and ITOSShould you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include Sage Therapeutics (SAGE), Jasper Therapeutics (JSPR), Valneva (VALN), C4 Therapeutics (CCCC), 4D Molecular Therapeutics (FDMT), Immutep (IMMP), COMPASS Pathways (CMPS), AC Immune (ACIU), Amylyx Pharmaceuticals (AMLX), and iTeos Therapeutics (ITOS). These companies are all part of the "pharmaceutical products" industry. Clearside Biomedical vs. Sage Therapeutics Jasper Therapeutics Valneva C4 Therapeutics 4D Molecular Therapeutics Immutep COMPASS Pathways AC Immune Amylyx Pharmaceuticals iTeos Therapeutics Clearside Biomedical (NASDAQ:CLSD) and Sage Therapeutics (NASDAQ:SAGE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability. Which has higher earnings and valuation, CLSD or SAGE? Clearside Biomedical has higher earnings, but lower revenue than Sage Therapeutics. Clearside Biomedical is trading at a lower price-to-earnings ratio than Sage Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearside Biomedical$7.70M8.59-$32.49M-$0.45-1.94Sage Therapeutics$106.40M3.23-$541.49M-$5.58-1.01 Do analysts rate CLSD or SAGE? Clearside Biomedical presently has a consensus target price of $5.33, suggesting a potential upside of 511.41%. Sage Therapeutics has a consensus target price of $11.53, suggesting a potential upside of 105.52%. Given Clearside Biomedical's stronger consensus rating and higher possible upside, analysts plainly believe Clearside Biomedical is more favorable than Sage Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Sage Therapeutics 2 Sell rating(s) 16 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CLSD or SAGE more profitable? Sage Therapeutics has a net margin of -317.29% compared to Clearside Biomedical's net margin of -413.83%. Clearside Biomedical's return on equity of 0.00% beat Sage Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Clearside Biomedical-413.83% N/A -92.90% Sage Therapeutics -317.29%-50.29%-45.48% Does the MarketBeat Community believe in CLSD or SAGE? Sage Therapeutics received 263 more outperform votes than Clearside Biomedical when rated by MarketBeat users. However, 67.28% of users gave Clearside Biomedical an outperform vote while only 65.39% of users gave Sage Therapeutics an outperform vote. CompanyUnderperformOutperformClearside BiomedicalOutperform Votes36867.28% Underperform Votes17932.72% Sage TherapeuticsOutperform Votes63165.39% Underperform Votes33434.61% Do insiders and institutionals have more ownership in CLSD or SAGE? 18.8% of Clearside Biomedical shares are owned by institutional investors. Comparatively, 99.2% of Sage Therapeutics shares are owned by institutional investors. 9.2% of Clearside Biomedical shares are owned by insiders. Comparatively, 5.5% of Sage Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer CLSD or SAGE? In the previous week, Sage Therapeutics had 1 more articles in the media than Clearside Biomedical. MarketBeat recorded 6 mentions for Sage Therapeutics and 5 mentions for Clearside Biomedical. Clearside Biomedical's average media sentiment score of 0.65 beat Sage Therapeutics' score of -0.02 indicating that Clearside Biomedical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearside Biomedical 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sage Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, CLSD or SAGE? Clearside Biomedical has a beta of 2.29, suggesting that its share price is 129% more volatile than the S&P 500. Comparatively, Sage Therapeutics has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. SummaryClearside Biomedical beats Sage Therapeutics on 11 of the 18 factors compared between the two stocks. Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLSD vs. The Competition Export to ExcelMetricClearside BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$66.16M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-1.9410.5991.3417.19Price / Sales8.59195.381,116.59116.80Price / CashN/A57.1642.6437.86Price / Book-3.495.104.794.78Net Income-$32.49M$151.51M$120.07M$225.60M7 Day Performance-14.48%-2.15%-1.89%-1.24%1 Month Performance-16.08%-3.14%11.45%3.36%1 Year Performance-16.13%11.50%30.61%16.58% Clearside Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLSDClearside Biomedical2.9023 of 5 stars$0.87-6.2%$5.33+511.4%-12.8%$66.16M$7.70M-1.9430News CoverageHigh Trading VolumeSAGESage Therapeutics4.1448 of 5 stars$5.17-4.1%$11.53+123.0%-73.1%$316.25M$86.46M-0.97690JSPRJasper Therapeutics2.3333 of 5 stars$21.00+1.9%$73.38+249.4%+290.1%$315.02MN/A-4.3520Positive NewsVALNValneva2.1578 of 5 stars$3.84-2.3%$18.50+381.8%-62.2%$312M$165.52M-30.23700News CoverageHigh Trading VolumeCCCCC4 Therapeutics2.0625 of 5 stars$4.34-0.9%$10.00+130.4%-9.2%$306.36M$33.67M-2.58150Analyst UpgradeNews CoveragePositive NewsFDMT4D Molecular Therapeutics2.5949 of 5 stars$6.61+1.7%$42.13+537.3%-66.9%$305.57M$17,000.00-2.28201Analyst ForecastIMMPImmutep1.4305 of 5 stars$2.06-5.5%$8.50+312.6%-13.2%$299.65M$5.14M0.002,021CMPSCOMPASS Pathways2.8367 of 5 stars$4.36+3.3%$33.60+670.6%-47.3%$298.32MN/A-1.92120Positive NewsACIUAC Immune2.4761 of 5 stars$2.97+0.7%$12.00+304.0%-33.8%$293.85M$16.48M-6.41140Positive NewsAMLXAmylyx Pharmaceuticals4.2412 of 5 stars$4.16+1.0%$7.33+76.3%-70.7%$285.16M$196.49M-1.08200Short Interest ↓News CoveragePositive NewsITOSiTeos Therapeutics3.4996 of 5 stars$7.78+1.3%$25.25+224.6%-28.4%$284.24M$35M-2.4490Analyst Forecast Related Companies and Tools Related Companies Sage Therapeutics Competitors Jasper Therapeutics Competitors Valneva Competitors C4 Therapeutics Competitors 4D Molecular Therapeutics Competitors Immutep Competitors COMPASS Pathways Competitors AC Immune Competitors Amylyx Pharmaceuticals Competitors iTeos Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLSD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
